AKEBIA THERAPEUTICS, INC. Increase (Decrease) in Accounts Receivable
AKEBIA THERAPEUTICS, INC. (AKBA) reported Increase (Decrease) in Accounts Receivable of $6.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$9.03M, a 178.34% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $15.70M, a 43.66% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$19.10M, a 721.28% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$6.16M, a 356.13% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2025 was $14.14M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2024 was -$4.05M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$994.00K.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2022 was -$11.30M, a 147.02% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed | Increase (Decrease) in Accounts Receivable 85 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.67M 10-Q · filed 2026-08-05 | -$12.43M derived: sum of 3 quarters · filed 2026-08-05 | -$18.59M derived: sum of 4 quarters · filed 2026-08-05 | |||||
| 2026-03-31 | $15.70M 10-Q · filed 2026-05-07 | -$3.39M derived: sum of 2 quarters · filed 2026-05-07 | -$9.55M derived: sum of 3 quarters · filed 2026-05-07 | $1.97M derived: sum of 4 quarters · filed 2026-08-05 | |||||
| 2025-12-31 | -$19.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$25.26M derived: sum of 2 quarters · filed 2026-02-26 | -$13.73M derived: sum of 3 quarters · filed 2026-08-05 | $14.14M 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | -$6.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $5.37M derived: sum of 2 quarters · filed 2026-08-05 | $33.24M 10-Q · filed 2025-11-10 | $36.31M derived: sum of 4 quarters · filed 2026-08-05 | |||||
| 2025-06-30 | $11.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $39.40M 10-Q · filed 2026-08-05 | $42.47M derived: sum of 3 quarters · filed 2026-08-05 | $44.88M derived: sum of 4 quarters · filed 2026-08-05 | |||||
| 2025-03-31 | $27.87M 10-Q · filed 2026-05-07 | $30.95M derived: sum of 2 quarters · filed 2026-05-07 | $33.35M derived: sum of 3 quarters · filed 2026-05-07 | $36.50M derived: sum of 4 quarters · filed 2026-05-07 | |||||
| 2024-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.48M derived: sum of 2 quarters · filed 2026-02-26 | $8.62M derived: sum of 3 quarters · filed 2026-02-26 | -$4.05M 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $5.55M derived: sum of 2 quarters · filed 2025-11-10 | -$7.12M 10-Q · filed 2025-11-10 | $9.58M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2024-06-30 | $3.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$9.53M 10-Q · filed 2025-08-07 | $7.17M derived: sum of 3 quarters · filed 2026-02-26 | $10.19M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2024-03-31 | -$12.67M 10-Q · filed 2025-05-08 | $4.03M derived: sum of 2 quarters · filed 2026-02-26 | $7.05M derived: sum of 3 quarters · filed 2026-02-26 | $7.89M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2023-12-31 | $16.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $19.72M derived: sum of 2 quarters · filed 2026-02-26 | $20.56M derived: sum of 3 quarters · filed 2026-02-26 | -$994.00K 10-K · filed 2026-02-26 | |||||
| 2023-09-30 | $3.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.86M derived: sum of 2 quarters · filed 2024-11-07 | -$17.69M 10-Q · filed 2024-11-07 | -$677.00K derived: sum of 4 quarters · filed 2024-11-07 | |||||
| 2023-06-30 | $841.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$20.71M 10-Q · filed 2024-08-08 | -$3.70M derived: sum of 3 quarters · filed 2024-08-08 | -$62.43M derived: sum of 4 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | -$21.55M 10-Q · filed 2024-05-09 | -$21.40M 10-Q · filed 2023-05-08 | -$4.54M derived: sum of 2 quarters · filed 2024-05-09 | -$63.27M derived: sum of 3 quarters · filed 2024-05-09 | -$46.63M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $17.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$41.72M derived: sum of 2 quarters · filed 2024-03-14 | -$25.07M derived: sum of 3 quarters · filed 2024-03-14 | -$11.30M 10-K · filed 2024-03-14 | -$11.70M 10-K · filed 2023-03-10 | ||||
| 2022-09-30 | -$58.73M derived: 10-Q 9 month − 10-K/A 6 month · filed 2023-11-08 | -$42.09M derived: sum of 2 quarters · filed 2023-11-08 | -$28.31M 10-Q · filed 2023-11-08 | -$27.78M 10-Q · filed 2022-11-03 | -$27.12M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $16.64M derived: 10-K/A 6 month − 10-K/A 3 month · filed 2023-08-28 | $30.42M 10-K/A · filed 2023-08-28 | $30.99M 10-Q · filed 2022-08-04 | $31.61M derived: sum of 3 quarters · filed 2023-08-28 | $46.30M derived: sum of 4 quarters · filed 2023-08-28 | ||||
| 2022-03-31 | $13.78M 10-K/A · filed 2023-08-28 | $13.71M 10-Q · filed 2022-05-09 | $14.97M derived: sum of 2 quarters · filed 2023-08-28 | $29.65M derived: sum of 3 quarters · filed 2023-08-28 | $29.43M derived: sum of 4 quarters · filed 2023-08-28 | ||||
| 2021-12-31 | $1.19M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | $15.88M derived: sum of 2 quarters · filed 2023-08-28 | $15.65M derived: sum of 3 quarters · filed 2023-08-28 | $24.03M 10-K/A · filed 2023-08-28 | $24.02M 10-K · filed 2022-03-01 | ||||
| 2021-09-30 | $14.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $14.46M derived: sum of 2 quarters · filed 2022-11-03 | $22.84M 10-Q · filed 2022-11-03 | $25.57M derived: sum of 4 quarters · filed 2023-08-28 | |||||
| 2021-06-30 | -$228.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $8.15M 10-Q · filed 2022-08-04 | $10.88M derived: sum of 3 quarters · filed 2023-08-28 | -$3.77M derived: sum of 4 quarters · filed 2023-08-28 | |||||
| 2021-03-31 | $8.38M 10-Q · filed 2022-05-09 | $11.11M derived: sum of 2 quarters · filed 2023-08-28 | -$3.54M derived: sum of 3 quarters · filed 2023-08-28 | -$69.30M derived: sum of 4 quarters · filed 2023-08-28 | |||||
| 2020-12-31 | $2.73M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | -$11.92M derived: sum of 2 quarters · filed 2023-08-28 | -$77.68M derived: sum of 3 quarters · filed 2023-08-28 | -$11.67M 10-K/A · filed 2023-08-28 | -$12.01M 10-K · filed 2021-02-25 | ||||
| 2020-09-30 | -$14.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$80.41M derived: sum of 2 quarters · filed 2021-11-04 | -$14.40M 10-Q · filed 2021-11-04 | -$5.19M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2020-06-30 | -$65.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $251.00K 10-Q · filed 2021-08-05 | $9.46M derived: sum of 3 quarters · filed 2022-03-01 | $10.23M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2020-03-31 | $66.01M 10-Q · filed 2021-05-10 | $75.22M derived: sum of 2 quarters · filed 2022-03-01 | $75.98M derived: sum of 3 quarters · filed 2022-03-01 | $56.44M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2019-12-31 | $9.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $9.98M derived: sum of 2 quarters · filed 2022-03-01 | -$9.57M derived: sum of 3 quarters · filed 2022-03-01 | $22.20M 10-K · filed 2022-03-01 | |||||
| 2019-09-30 | $766.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$18.78M derived: sum of 2 quarters · filed 2020-11-05 | $12.99M 10-Q · filed 2020-11-05 | $13.13M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2019-06-30 | -$19.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $12.22M 10-Q · filed 2020-08-10 | $12.37M derived: sum of 3 quarters · filed 2021-02-25 | $12.92M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2019-03-31 | $31.77M 10-Q · filed 2020-05-05 | $31.91M derived: sum of 2 quarters · filed 2021-02-25 | $32.47M derived: sum of 3 quarters · filed 2021-02-25 | -$3.25M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2018-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $700.00K derived: sum of 2 quarters · filed 2021-02-25 | -$35.02M derived: sum of 3 quarters · filed 2021-02-25 | -$33.38M 10-K · filed 2021-02-25 | |||||
| 2018-09-30 | $556.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$35.16M derived: sum of 2 quarters · filed 2019-11-12 | -$33.53M 10-Q · filed 2019-11-12 | $407.00K derived: sum of 4 quarters · filed 2020-03-12 | |||||
| 2018-06-30 | -$35.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$34.08M 10-Q · filed 2019-08-08 | -$149.00K derived: sum of 3 quarters · filed 2020-03-12 | $132.00K derived: sum of 4 quarters · filed 2020-03-12 | |||||
| 2018-03-31 | $1.64M 10-Q · filed 2019-05-09 | $35.57M derived: sum of 2 quarters · filed 2020-03-12 | $35.85M derived: sum of 3 quarters · filed 2020-03-12 | $35.85M derived: sum of 4 quarters · filed 2020-03-12 | |||||
| 2017-12-31 | $33.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $34.22M derived: sum of 2 quarters · filed 2020-03-12 | $34.22M derived: sum of 3 quarters · filed 2020-03-12 | $393.00K 10-K · filed 2020-03-12 | |||||
| 2017-09-30 | $281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $281.00K derived: sum of 2 quarters · filed 2018-11-08 | -$33.54M 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$33.82M 10-Q · filed 2018-08-08 | |||||||
| 2017-03-31 | -$33.82M 10-Q · filed 2018-05-09 | ||||||||
| 2016-12-31 | $33.82M 10-K · filed 2019-03-26 | ||||||||
| 2015-09-30 | -$34.00K 10-Q · filed 2015-11-09 | ||||||||
| 2015-03-31 | $26.00K 10-Q · filed 2015-05-11 | $17.00K derived: sum of 2 quarters · filed 2015-05-11 | -$40.00K derived: sum of 3 quarters · filed 2015-11-09 | -$45.00K derived: sum of 4 quarters · filed 2015-11-09 | |||||
| 2014-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | -$66.00K derived: sum of 2 quarters · filed 2015-11-09 | -$71.00K derived: sum of 3 quarters · filed 2015-11-09 | -$87.00K 10-K · filed 2015-03-04 | |||||
| 2014-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$62.00K derived: sum of 2 quarters · filed 2015-11-09 | -$78.00K 10-Q · filed 2015-11-09 | -$108.00K derived: sum of 4 quarters · filed 2015-11-09 | |||||
| 2014-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$21.00K 10-Q · filed 2015-08-11 | -$21.39K 10-Q · filed 2014-08-11 | -$51.00K derived: sum of 3 quarters · filed 2015-08-11 | -$95.90K derived: sum of 4 quarters · filed 2015-08-11 | ||||
| 2014-03-31 | -$16.00K 10-Q · filed 2015-05-11 | -$15.94K 10-Q · filed 2014-05-12 | -$46.00K derived: sum of 2 quarters · filed 2015-05-11 | -$90.90K derived: sum of 3 quarters · filed 2015-05-11 | $20.17K derived: sum of 4 quarters · filed 2015-05-11 | $119.39K 10-Q · filed 2014-05-12 | |||
| 2013-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | -$74.90K derived: sum of 2 quarters · filed 2015-03-04 | $36.17K derived: sum of 3 quarters · filed 2015-03-04 | $50.00K 10-K · filed 2015-03-04 | |||||
| 2013-09-30 | -$44.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $66.17K derived: sum of 2 quarters · filed 2014-11-10 | $80.00K 10-Q · filed 2014-11-10 | ||||||
| 2013-06-30 | $111.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $124.90K 10-Q · filed 2014-08-11 | |||||||
| 2013-03-31 | $13.83K 10-Q · filed 2014-05-12 | ||||||||
| 2012-12-31 | $4.00K 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |